RE: Rns breakdown10 Mar 2025 09:31
Based on my calculations, the potential revenue for Polarean Imaging plc’s expanded Xenon MRI imaging platform can range significantly depending on the number of clinical trials it supports per year.
• If 5 trials are conducted annually, the estimated revenue would be between $2.5 million and $10 million.
• If 10 trials are conducted annually, the estimated revenue would be between $5 million and $20 million.
• If 15 trials are conducted annually, the estimated revenue would be between $7.5 million and $30 million.
• If 20 trials are conducted annually, the estimated revenue would be between $10 million and $40 million.
These estimates are based on each trial generating between $500,000 to $2 million in revenue. The actual figures will depend on the pricing structure, level of adoption, and the number of trials secured. If Polarean can scale this successfully, it could significantly boost their revenue.